A. M. Tanner

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy.

W. Bennett, W. Border, N. Noble, 1996, Kidney international.

Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip.

T. Cook, A. Hofmann, A. M. Tanner, 2005, The Journal of arthroplasty.

Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.

W. Bennett, T. Andoh, F. Shihab, 1997, Kidney international.

Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection.

F. Shihab, Y. Shao, A. M. Tanner, 1996, Kidney international.

Mechanism of fibrosis in experimental tacrolimus nephrotoxicity.

W. Bennett, T. Andoh, F. Shihab, 1997, Transplantation.

Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy.

W. Bennett, T. Andoh, F. Shihab, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Clinical and radiographic analysis of accurate restoration of the joint line in revision total knee arthroplasty.

M. Bolognesi, A. Hofmann, A. M. Tanner, 2006, The Journal of arthroplasty.

Treatment of Infected Total Knee Arthroplasty Using an Articulating Spacer: 2- to 12-Year Experience

A. Hofmann, A. M. Tanner, T. Goldberg, 2005, Clinical orthopaedics and related research.

Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis.

W. Bennett, H. Yi, T. Andoh, 1999, Kidney international.

Surface cementation of stemmed tibial components in primary total knee arthroplasty: minimum 5-year follow-up.

T. Cook, A. Hofmann, A. M. Tanner, 2006, The Journal of arthroplasty.

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy.

W. Bennett, W. Border, N. Noble, 1996, Kidney international.